Steve Cullen, Financial Director, bought 16,089 shares in the company on the 25th November 2019 at a price of 38.53p. The Director now holds 1,387,633...

Warren Finegold, Non Executive Director, exercised 51,224 shares in the company on the 25th November 2019 at a price of 65.00p. The Director now holds...

Warren Finegold, Non Executive Director, exercised 233,034 shares in the company on the 25th November 2019 at a price of 136.00p. The Director now holds...

Warren Finegold, Non Executive Director, sold post-exercise 284,258 shares in the company on the 25th November 2019 at a price of 444.06p.

Director deals data...

Andy Cosslett, Chairman, bought 73,643 shares in the company on the 25th November 2019 at a price of 203.68p. The Director now holds 290,866 shares....

Mark Seligman, Non Executive Director, bought 10,000 shares in the company on the 25th November 2019 at a price of 201.77p. The Director now holds...

UK stocks ended Tuesday in positive territory as top US and China trade negotiators continue to work on a potential deal.

The benchmark FTSE 100...

Allergy Therapeutics said a study evaluating an allergy vaccine would now be split into two stages.

The study was originally planned for the 2020/2021 pollen...

Property investor LXi REIT said its first-half profit almost doubled amid a rise in rental income and upward revaluation of its assets.

Pre-tax profit for...

Private equity investor Princess Private Equity said its net asset value decreased by 0.4% during the month of October.

Positive portfolio developments were offset by...